We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Proteinuria After Acute Kidney Injury Predicts Development of Progressive Disease

By LabMedica International staff writers
Posted on 03 Feb 2020
A report has suggested that testing recently hospitalized kidney patients for proteinuria could be a way to identify those at higher risk for developing progressive kidney disease, which could require dialysis or surgery.

Clinicians agree that among patients who had acute kidney injury (AKI) during hospitalization, there is a need to improve risk prediction so that those at highest risk for subsequent loss of kidney function are identified for appropriate follow-up. More...


To this end, investigators at the University of California, San Francisco (USA) and colleagues at several other institutions worked with participants in The Assessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury (ASSESS-AKI) Study. This was a multicenter prospective cohort study including four clinical centers in North America that included 1538 patients enrolled three months after hospital discharge between December 2009 and February 2015. Of the 1538 participants, 769 (50%) had AKI during hospitalization.

To detect proteinuria, the investigators measured urine albumin-to-creatinine ratio (ACR) three months after hospital discharge. The mean age of the patients was 65 years, and the median urine ACR was 15 milligrams per gram. Overall, 547 (37%) of the participants were women and 195 (13%) were black.

Results revealed that after a median follow-up of 4.7 years, 138 (9%) participants had kidney disease progression. Higher post-AKI urine ACR level was associated with increased risk of kidney disease progression, and urine ACR measurement was a strong discriminator for future kidney disease progression. The performance of urine ACR was stronger in patients who had had AKI than in those who had not.

"There should be much more emphasis on the testing of proteinuria after AKI to identify high-risk patients," said first author Dr. Chi-yuan Hsu, professor of nephrology at the University of California, San Francisco. "This simple test carries important prognostic information not conveyed by serum creatinine. Too many providers rely on serum creatinine alone to assess the health of the kidneys, but they should not be falsely assured by the latter. Having a more complete picture of kidney health is necessary for proper clinical decision-making."

"Most patients with acute kidney injury are unaware of their condition, lack understanding of its natural history or predisposing factors, and desire more information," said Dr. Hsu. "However, few discharge communications currently provided to these patients explain the condition or provide recommendations for care, which is needed throughout the care continuum."

The AKI study was published in the January 27, 2020, online edition of the journal JAMA Internal Medicine.

Related Links:
University of California, San Francisco


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Portable Electronic Pipette
Mini 96
Human Estradiol Assay
Human Estradiol CLIA Kit
New
Gold Member
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.